News & Views | Published:

Ironing out VPS34 inhibition

Nature Cell Biology volume 17, pages 13 (2015) | Download Citation

Subjects

The class III phosphoinositide 3-kinase VPS34 regulates autophagosome formation. Three groups have developed VPS34 inhibitors and shown their utility in investigating and defining autophagic processes.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Annu. Rev. Pathol. 8, 105–137 (2013).

  2. 2.

    et al. Science 260, 88–91 (1993).

  3. 3.

    et al. EMBO J. 14, 3339–3348 (1995).

  4. 4.

    , , & Nat. Rev. Mol. Cell Biol. 11, 329–341 (2010).

  5. 5.

    Nat. Rev. Mol. Cell Biol. 9, 99–111 (2008).

  6. 6.

    et al. Nat. Cell Biol. 16, 1069–1079 (2014).

  7. 7.

    et al. Nat. Chem. Biol. 10, 1013–1019 (2014).

  8. 8.

    et al. Biochem. J. 463, 413–427 (2014).

  9. 9.

    , & Mol. Cell. 53, 167–178 (2014).

  10. 10.

    et al. Nature. 509, 105–109 (2014).

  11. 11.

    et al. EMBO J. 32, 566–582 (2013).

  12. 12.

    & Proc. Natl Acad. Sci. USA 93, 5517–5521 (1996).

  13. 13.

    et al. Mol. Cell Biol. 31, 2040–2052 (2011).

  14. 14.

    , , & J. Cell Sci. 127, 4089–4102 (2014).

  15. 15.

    , , & Biochemistry. 51, 5705–5724 (2012).

Download references

Author information

Affiliations

  1. Timothy Marsh and Jayanta Debnath are in the Department of Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 513 Parnassus Ave, HSW450, San Francisco, California 94143, USA

    • Timothy Marsh
    •  & Jayanta Debnath

Authors

  1. Search for Timothy Marsh in:

  2. Search for Jayanta Debnath in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Jayanta Debnath.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ncb3089

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing